Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mercaptopurine 45mg/5ml oral suspension
0801030L0AAAKAK
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 50mg/5ml oral suspension
0801030L0AAAFAF
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 5mg/5ml oral suspension
0801030L0AAACAC
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 75mg capsules
0801030L0AAAPAP
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 75mg/5ml oral suspension
0801030L0AAAIAI
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mesna 1g/10ml solution for injection ampoules
0801000T0AAABAB
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Mesna 400mg/4ml solution for injection ampoules
0801000T0AAAAAA
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Mesna 40mg/5ml oral solution
0801000T0AAAEAE
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Mesna 600mg tablets
0801000T0AAADAD
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 1g/40ml solution for injection vials
0801030P0AACTCT
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 200mg/8ml solution for injection vials
0801030P0AAASAS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 25mg/3ml inj pre-filled syringes
0801030P0AAFDFD
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 27.5mg/1.1ml inj pre-filled syringes
0801030P0AADRDR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 30mg/1.2ml inj pre-filled syringes
0801030P0AACGCG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 32.5mg/1.3ml inj pre-filled syringes
0801030P0AAEAEA
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 35mg/1.4ml inj pre-filled syringes
0801030P0AADNDN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 500mg/20ml solution for injection vials
0801030P0AAAKAK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 50mg/2ml inj pre-filled syringes
0801030P0AADVDV
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5g/200ml solution for infusion vials
0801030P0AACUCU
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5g/50ml solution for infusion vials
0801030P0AACSCS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5mg/0.2ml inj pre-filled syringes
0801030P0AABPBP
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Midostaurin 25mg capsules
0801050CKAAAAAA
|
Midostaurin | Midostaurin | Malignant Disease and Immunosuppression | No data available |
|
Mitocin 20mg powder for solution for injection vials
0801020Q0BCAAAG
|
Mitocin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin 10mg powder for solution for injection vials
0801020Q0AAAFAF
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin 20mg powder for solution for injection vials
0801020Q0AAAGAG
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.